| Host: | Rabbit | 
| Applications: | WB/IHC | 
| Reactivity: | Human/Mouse | 
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. | 
| Short Description : | Rabbit polyclonal antibody anti-Splicing factor, arginine/serine-rich 19 (41-90 aa) is suitable for use in Western Blot and Immunohistochemistry research applications. | 
| Clonality : | Polyclonal | 
| Conjugation: | Unconjugated | 
| Isotype: | IgG | 
| Formulation: | Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. | 
| Purification: | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. | 
| Concentration: | 1 mg/mL | 
| Dilution Range: | WB 1:500-2000IHC-P 1:50-300 | 
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. | 
| Gene Symbol: | SCAF1 | 
| Gene ID: | 58506 | 
| Uniprot ID: | SFR19_HUMAN | 
| Immunogen Region: | 41-90 aa | 
| Specificity: | SCAF1 Polyclonal Antibody detects endogenous levels of SCAF1 protein. | 
| Immunogen: | The antiserum was produced against synthesized peptide derived from the human SFRS19 at the amino acid range 41-90 | 
| Function | May function in pre-mRNA splicing. | 
| Protein Name | Splicing Factor - Arginine/Serine-Rich 19Sr-Related C-Terminal Domain-Associated Factor 1Sr-Related And Ctd-Associated Factor 1Sr-Related-Ctd-Associated FactorScafSerine Arginine-Rich Pre-Mrna Splicing Factor Sr-A1Sr-A1 | 
| Cellular Localisation | Nucleus | 
| Alternative Antibody Names | Anti-Splicing Factor - Arginine/Serine-Rich 19 antibodyAnti-Sr-Related C-Terminal Domain-Associated Factor 1 antibodyAnti-Sr-Related And Ctd-Associated Factor 1 antibodyAnti-Sr-Related-Ctd-Associated Factor antibodyAnti-Scaf antibodyAnti-Serine Arginine-Rich Pre-Mrna Splicing Factor Sr-A1 antibodyAnti-Sr-A1 antibodyAnti-SCAF1 antibodyAnti-SFRS19 antibodyAnti-SRA1 antibody | 
Information sourced from Uniprot.org
                    
                    
                       
                    
